A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol.Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. JCI Insight.
A new combined therapy to boost the immune system against cancer. Liver fat may disrupt post-meal glucagon control in early type 2 diabetes.
The information demonstrated a number of new dual agonists that target the glucose-dependent insulinotropic polypeptide (GIP) receptor as well as the glucagon-like peptide-1 (GLP-1).
This particular example perfectly highlights why New Insights Glucagon is so captivating.
